Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) as a Primary Preventative Agent in the Healthy Individual: A Need of a Future Randomised Clinical Trial?

Overview of attention for article published in Frontiers in Medicine, August 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

So far, Dimensions has found 18 publications that cite this research output.

Article in Gastric Cancer (June 2024)

Article in GeroScience (May 2024)

Article in Diabetology & Metabolic Syndrome (April 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.